- Target
- CD26
- Reactivity
- Human
- Application
- ELISA,FC
- MW(Calculated)
- --
- MW(Observed)
- --
- Host Species
- Camel
- Isotype
- --
- Conjugate/Modification
- Unmodified
- Modification site
- --
- Recommended Dilution Ratio
- ELISA 1:5000-100000;Flow Cyt 1-2μg/Test
- Form
- Phosphate-buffered solution
- Source
- Camel, chimeric fusion of Nanobody (VHH) and mouse IgG1 Fc domain , recombinantly produced from 293F cell
- Purification
- Recombinant Expression and Affinity purified
- Purity
- --
- storageCondition
- -15°C to -25°C/1 year(Avoid freeze / thaw cycles)
- Concentration
- Please check the information on the tube
- Clonality
- Monoclonal
- Clone No.
- PN0210
- Immunogen
- Purified recombinant Human CD26
- Sequence
- --
- Specificity
- This recombinant monoclonal antibody can detects endogenous levels of CD26 protein.
- Gene Name
- DPP4 ADCP2 CD26
- Protein Name
- CD82 antigen (C33 antigen) (IA4) (Inducible membrane protein R2) (Metastasis suppressor Kangai-1) (Suppressor of tumorigenicity 6 protein) (Tetraspanin-27) (Tspan-27) (CD antigen CD82)
- Other Name
- 4F9 antibody;Antigen detected by monoclonal and antibody IA4 antibody;C33 antibody;C33 antigen antibody;CD 82 antibody;CD82 antibody;CD82 antigen antibody;CD82 molecule antibody;CD82_HUMAN antibody;GR 15 antibody;GR15 antibody;IA 4 antibody;IA4 antibody;Inducible membrane protein antibody;Inducible membrane protein R2 antibody;KAI 1 antibody;KAI1 antibody;Kangai 1;suppression of tumorigenicity 6;prostate;CD82 antigen;R2 leukocyte antigen;antigen detected by monoclonal and antibody IA4;antibody;Kangai 1 antibody;Kangai1 antibody;Leukocyte surface antigen R2 antibody;Metastasis suppressor Kangai 1 antibody;Metastasis suppressor Kangai-1 antibody;Metastasis suppressor Kangai1 antibody;Prostate cancer antimetastasis gene KAI1 antibody;R2 antibody;R2 leukocyte antigen antibody;SAR 2 antibody;SAR2 antibody;ST 6 antibody;ST6 antibody;Suppression of tumorigenicity 6 antibody;Suppression of tumorigenicity 6 prostate antibody;Suppressor of tumorigenicity 6 antibody;Suppressor of tumorigenicity 6 protein antibody;Tetraspanin 27 antibody;Tetraspanin-27 antibody;Tetraspanin27 antibody;Tspan 27 antibody;Tspan-27 antibody;Tspan27 antibody;CD82 nanobody;
- Organism-1
- Human
- Gene ID-1
- 1803
- SwissProt-1
- P27487
- Organism-2
- --
- Gene ID-2
- --
- SwissProt-2
- --
- Organism-3
- --
- Gene ID-3
- --
- SwissProt-3
- --
- Organism-4
- --
- gene ID-4
- --
- SwissProt-4
- --
- Cellular Localization
- [Dipeptidyl peptidase 4 soluble form]: Secreted . Detected in the serum and the seminal fluid. .; Cell membrane ; Single-pass type II membrane protein. Apical cell membrane ; Single-pass type II membrane protein. Cell projection, invadopodium membrane ; Single-pass type II membrane protein. Cell projection, lamellipodium membrane ; Single-pass type II membrane protein. Cell junction . Membrane raft . Translocated to the apical membrane through the concerted action of N- and O-Glycans and its association with lipid microdomains containing cholesterol and sphingolipids (PubMed:11773049). Redistributed to membrane rafts in T-cell in an interleukin-12-dependent activation (PubMed:12676959). Its interaction with CAV1 is necessary for its translocation to membrane rafts (PubMed:17287217). Colocalized with PTPRC in membrane rafts (PubMed:12676959). Colocalized with FAP in invadopodia and lamellipodia of migratory activated endothelial cells in collagenous matrix. Colocalized with FAP on endothelial cells of capillary-like microvessels but not large vessels within invasive breast ductal carcinoma (PubMed:16651416). Colocalized with ADA at the cell junction in lymphocyte-epithelial cell adhesion (PubMed:11772392). Colocalized with IGF2R in internalized cytoplasmic vesicles adjacent to the cell surface (PubMed:10900005). .